ADRMF (Adherium) 3-Month Share Buyback Ratio: 0.00% (As of Dec. 2025 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ADRMF Adherium Ltd ADRMF
5 GF Score
Price $0.30
GF Value $1.02
! 8 Warning Signs
View Full Analysis

What is Adherium 3-Month Share Buyback Ratio?

Adherium ADRMF 5 3-Month Share Buyback Ratio is 0.00 as of Dec. 2025. GuruFocus rates ADRMF with a GF Score™ of 5/100 and a GF Value™ of $1.02. The stock has 8 warning signs investors should review.

3-Month Share Buyback Ratio only apply to companies whose reporting frequency is 3 months.

ADRMF
5GF Score
Adherium Ltd ADRMF
3-Month Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a 3-Month Share Buyback Ratio of 0.00 mean?
Adherium (ADRMF) has a 3-Month Share Buyback Ratio of 0.00 as of Dec. 2025. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Adherium and its competitors.
Is Adherium's 3-Month Share Buyback Ratio too high?
Adherium's current 3-Month Share Buyback Ratio is 0.00. Overall, Adherium has a GF Score™ of 5/100, reflecting its overall financial health beyond just this single metric.
How does Adherium's 3-Month Share Buyback Ratio compare to ABT and SYK?
Adherium's 3-Month Share Buyback Ratio of 0.00 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Month Share Buyback Ratio for a Medical Devices & Instruments company?
A good 3-Month Share Buyback Ratio depends on the Medical Devices & Instruments industry context. However, 3-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Month Share Buyback Ratio mean?
A high 3-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for Adherium and its competitors. Adherium's current 3-Month Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adherium stock overvalued right now?
Adherium (ADRMF) has a current 3-Month Share Buyback Ratio of 0.00. The stock's GF Value™ is $1.02, compared to a current price of $0.30 — trading 70.6% below its estimated fair value. The current 3-Month Share Buyback Ratio is 0.00. Adherium's overall GF Score™ is 5/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Month Share Buyback Ratio calculated?
3-Month Share Buyback Ratio is calculated from a company's financial statements. For Adherium (ADRMF), the current 3-Month Share Buyback Ratio is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Adherium (ADRMF) Overvalued in 2026?

Based on GuruFocus' analysis, Adherium stock appears to be undervalued. The current stock price of $0.30 is trading 70.6% below its estimated GF Value™ of $1.02.

Key valuation signals for ADRMF:

  • 3-Month Share Buyback Ratio: 0.00
  • GF Value™: $1.02 vs. price of $0.30 (70.6% below fair value)
  • GF Score™: 5/100 with 8 warning signs

No single metric tells the full story. See the ADRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Adherium Business Description

Other Exchanges ADR:Australia
Address 447 Collins Street, Level 5, Melbourne, VIC, AUS, 3000
Adherium Ltd is engaged in the development, manufacture, and supply of its Hailie digital health technologies that address sub-optimal medication use and improve health outcomes in chronic disease. It is an international Respiratory eHealth company focused on patient medication adherence, remote monitoring, and data management solutions for patients, payers, and providers. Its geographically segments include New Zealand and Australia, Europe, North America, and Asia. The majority of its revenue comes from Europe.
5GF Score

Get the complete analysis for ADRMF

3-Month Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.30
Price
$1.02
GF Value